Synlogic, Inc.
Doing business as Synlogic
- UEI
- YLNVRJ527NF1
- CAGE
- 54S51
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A new microrna-1291 replacement therapy for pancreatic cancer disease | National Institutes of Health | $113,864 | |
| Therapeutic mirnas in combination with conventional chemotherapy | National Institutes of Health | $299,999 | |
| Systemic delivery of chitosan/mirna nanoparticles to prostate tumors | National Institutes of Health | $299,999 | |
| Microrna therapeutics for prostate cancer | National Institutes of Health | $282,967 | |
| Development of modified microrna therapeutics | National Institutes of Health | $287,270 |
Quick answers
What is Synlogic, Inc.'s UEI?
Synlogic, Inc.'s Unique Entity ID (UEI) in SAM.gov is YLNVRJ527NF1.
What is Synlogic, Inc.'s CAGE code?
Synlogic, Inc.'s CAGE code is 54S51.
Is Synlogic, Inc. registered in SAM.gov?
Synlogic, Inc.'s SAM.gov registration expired on August 24, 2024.
What is Synlogic, Inc.'s most recent federal award?
Synlogic, Inc.'s most recent federal grant award is A new microrna-1291 replacement therapy for pancreatic cancer disease (R41AA024029), from National Institutes of Health, on September 15, 2014.
On GovTribe
See Synlogic, Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors